Clinical effects of everolimus in the subjects with tuberous sclerosis.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Tuberous sclerosis
- Focus Therapeutic Use
- 27 Aug 2017 Status changed from not yet recruiting to suspended.
- 27 Sep 2016 New trial record